QIX Deutschland
17.094,83
PKT
+22,54
PKT
+0,13
%
Werbung
Analysen zu QIX Deutschland-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.02.26 | Brenntag Sell | UBS AG | |
| 16.02.26 | Evonik Neutral | UBS AG | |
| 16.02.26 | Deutsche Börse Neutral | Goldman Sachs Group Inc. | |
| 16.02.26 | Gerresheimer Hold | Deutsche Bank AG | |
| 16.02.26 | Carl Zeiss Meditec Hold | Deutsche Bank AG | |
| 16.02.26 | Carl Zeiss Meditec Market-Perform | Bernstein Research | |
| 16.02.26 | Gerresheimer Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.02.26 | Deutsche Börse Kaufen | DZ BANK | |
| 13.02.26 | Carl Zeiss Meditec Neutral | Goldman Sachs Group Inc. | |
| 13.02.26 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 13.02.26 | Deutsche Börse Overweight | Barclays Capital | |
| 13.02.26 | Carl Zeiss Meditec Equal Weight | Barclays Capital | |
| 12.02.26 | Evonik Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.02.26 | Gerresheimer Underperform | Bernstein Research | |
| 12.02.26 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 12.02.26 | Carl Zeiss Meditec Market-Perform | Bernstein Research | |
| 12.02.26 | freenet Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.02.26 | Deutsche Börse Hold | Warburg Research | |
| 12.02.26 | Carl Zeiss Meditec Neutral | UBS AG | |
| 12.02.26 | Deutsche Börse Neutral | UBS AG | |
| 12.02.26 | Bechtle Buy | UBS AG | |
| 12.02.26 | Deutsche Börse Overweight | Barclays Capital | |
| 12.02.26 | Carl Zeiss Meditec Equal Weight | Barclays Capital | |
| 12.02.26 | Gerresheimer Hold | Deutsche Bank AG | |
| 12.02.26 | Deutsche Börse Buy | Deutsche Bank AG | |
| 12.02.26 | CANCOM Buy | Jefferies & Company Inc. | |
| 12.02.26 | Carl Zeiss Meditec Sector Perform | RBC Capital Markets | |
| 12.02.26 | Deutsche Börse Hold | Jefferies & Company Inc. | |
| 12.02.26 | Deutsche Börse Overweight | JP Morgan Chase & Co. | |
| 11.02.26 | Deutsche Börse Sector Perform | RBC Capital Markets | |
| 11.02.26 | Gerresheimer Verkaufen | DZ BANK | |
| 11.02.26 | Evonik Halten | DZ BANK | |
| 11.02.26 | Gerresheimer Neutral | UBS AG | |
| 11.02.26 | Gerresheimer Equal Weight | Barclays Capital | |
| 11.02.26 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 11.02.26 | Gerresheimer Overweight | JP Morgan Chase & Co. | |
| 10.02.26 | Merck Buy | Goldman Sachs Group Inc. | |
| 10.02.26 | Fresenius Medical Care (FMC) St. Sell | UBS AG | |
| 10.02.26 | Symrise Buy | Goldman Sachs Group Inc. | |
| 10.02.26 | Evonik Buy | Goldman Sachs Group Inc. |